Survey: Few Women With Uterine Fibroids Offered Less Invasive Treatment Options

Medically reviewed by Drugs.com.

By Lori Solomon HealthDay Reporter

WEDNESDAY, July 24, 2024 -- Most U.S. women with uterine fibroids report being offered hysterectomies over minimally invasive treatments, according to survey results released by the Society of Interventional Radiology.

The online survey, conducted by the Harris Poll from May 30 to June 3, 2024, included 1,122 U.S. women (≥18 years), including 167 who reported being personally diagnosed with uterine fibroids.

Results showed that more than half of respondents with fibroids (53 percent) were presented with a hysterectomy, while fewer than one in five were presented with less invasive options such as over-the-counter nonsteroidal anti-inflammatory drugs (19 percent), uterine fibroid embolization (17 percent), oral contraceptives (17 percent), and endometrial ablation (17 percent). More than one in six women (17 percent) mistakenly believed a hysterectomy is the only treatment option, which was even more common in younger women (aged 18 to 34 years: 27 percent).

"The survey noted deep disparities in awareness and access regarding fibroids and fibroid treatments among Black and Hispanic women, who have a higher risk factor for developing uterine fibroids," Robert J. Lewandowski, M.D., president of the Society of Interventional Radiology, said in a statement. "The data serve as a guiding light for improving physician and patient educational efforts on various treatments to ensure all women, regardless of background, are informed about their risks and the full range of treatment options available."

More Information

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords